Rigshospitalet

• Martin Sillesen

  Lead investigator

• Miriam Kolko

  Lead investigator

• Klaus Fuglsang Kofoed

  Lead investigator

• Rigmor Hoejland Jensen

  Lead investigator

• Finn Gustafsson

  Lead investigator

Sources: openalex.org

• Novo Nordisk Foundation

  Pioneer Innovator, USING TRANSFORMER-BASED DEEP LEARNING ON EPIGENETIC MARKERS TO BUILD TOMORROWS COMPLEX BIOMARKERS FOR SURGICAL FRAILTY, nnf-grant-5bdb02cf669a0e4a, DKK 1.1m, 2024, 1 Jan 2024

• Novo Nordisk Foundation

  Additive Benefits of Semaglutide for open-AngLe glaucoma – an Opportunity for Neuroprotection (ABSALON), nnf-grant-af5110c3d7ec3efc, DKK 7.4m, 2022, 1 Jan 2022

• Novo Nordisk Foundation

  Tandem Programme, Artificial intelligence-driven 3D image analysis and radiomics for high quality personalized cardiovascular risk assessment - The ARTICHOKE STUDY, nnf-grant-5b4e5f3dae0a19e0, DKK 9.3m, 2022, 1 Jan 2022

• Novo Nordisk Foundation

  Projektstøtte i klinisk og translationel lægevidenskab, GLP-1 Assisted Rapid Weight-Loss Program as Treatment of Idiopathic Intracranial Hypertension, nnf-grant-33db6ed0b47cba13, DKK 3m, 2020, 1 Jan 2020

• Novo Nordisk Foundation

  Projektstøtte i klinisk og translationel lægevidenskab, A randomized, double-blind, placebo controlled study of Hydralazine-ISDN and Metformin in patients with chronic heart, nnf-grant-43ea5d61b7d07414, DKK 1.6m, 2018, 1 Jan 2018

Sources: openalex.org

• Immune-inflammatory profiles, coronary artery disease, and peripheral artery disease in people with HIV

  E-23719-25, E-23719-14, 8 Oct 2026

Sources: api.crossref.org

• Impact of pre-admission functional status on intensive care patient outcomes: a systematic review and meta-analysis

  Grants or research support, 28 Aug 2026

• Senescence profiling and biomarker identification in cell product based on adipose tissue-derived mesenchymal stromal cells

  Shares or equity, Patents or royalties, 25 Feb 2026

Sources: pubmed.ncbi.nlm.nih.gov